×
About 2,323 results

ALLMedicine™ Uterine Cancer Center

Research & Reviews  597 results

Power-morcellation hysterectomies declined and most performed with no containment bag
https://www.mdedge.com/obgyn/article/256908/surgery/power-morcellation-hysterectomies-declined-and-most-performed-no
Diana Swift

Aug 9th, 2022 - The use of laparoscopic power morcellators for minimally invasive hysterectomy has significantly decreased, and while the use of containment bags increased after the U. S.

Second Cancer After Additive Chemotherapy in Patients With Colon Cancer.
https://doi.org/10.1016/j.clcc.2022.07.002
Clinical Colorectal Cancer; Teufel A, Li M et. al.

Aug 8th, 2022 - Additive chemotherapeutic treatment of UICC-stage -III / IV colon cancer with fluorouracil, leucovorin and oxaliplatin is widely accepted as current standard of treatment after R0-resection. However, as patients´ survival is increasing, long-term ...

An Arts-Based Workshop Using Scalp Tattoos to Connect Students with Cancer Patients' Ex...
https://doi.org/10.1097/ACM.0000000000004705
Academic Medicine : Journal of the Association of America... Clements ML, Wimbish PW et. al.

Aug 3rd, 2022 - Students eager to enter the medical field must develop perspective-taking skills that enhance their ability to connect with patients. Toward this goal, the authors developed a pilot workshop for undergraduate students that included an art activity...

Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protei...
https://doi.org/10.1016/j.gene.2022.146765
Gene Wang T, Zhu T et. al.

Jul 30th, 2022 - BRCA1-associated protein 1 gene (BAP1) plays a key role in some cancers. However, it has not yet been elucidated whether BAP1 modulates the pathogenesis and progression of human cancers through some common cellular and molecular mechanisms, and a ...

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
https://clinicaltrials.gov/ct2/show/NCT04579380

Jul 26th, 2022 - There are multiple cohorts in this trial: 5 tumor specific cohorts with HER2 overexpression/amplification (cervical cancer, uterine cancer, biliary tract cancer, urothelial cancer, and non-squamous non-small cell lung cancer [NSCLC]) 2 tumor speci...

see more →

Guidelines  4 results

Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Ear...
https://doi.org/10.1097/AOG.0000000000002289
Obstetrics and Gynecology;

Aug 24th, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

Committee Opinion No. 716: The Role of the Obstetrician-Gynecologist in the Early Detec...
https://doi.org/10.1097/AOG.0000000000002299
Obstetrics and Gynecology;

Aug 24th, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

BGCS uterine cancer guidelines: Recommendations for practice.
https://doi.org/10.1016/j.ejogrb.2017.04.015
European Journal of Obstetrics, Gynecology, and Reproduct... Sundar S, Balega J et. al.

Apr 25th, 2017 - The British Gynaecological Cancer Society has issued the first Endometrial (Uterine) Cancer guidelines as recommendation for practice for the UK.

Uterine neoplasms, version 1.2014.
https://doi.org/10.6004/jnccn.2014.0025
Journal of the National Comprehensive Cancer Network : JN... Koh WJ, Greer BE et. al.

Mar 4th, 2014 - Adenocarcinoma of the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uteri...

see more →

Drugs  48 results see all →

Clinicaltrials.gov  61 results

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
https://clinicaltrials.gov/ct2/show/NCT04579380

Jul 26th, 2022 - There are multiple cohorts in this trial: 5 tumor specific cohorts with HER2 overexpression/amplification (cervical cancer, uterine cancer, biliary tract cancer, urothelial cancer, and non-squamous non-small cell lung cancer [NSCLC]) 2 tumor speci...

Adipocytokines in Endometrial Cancer
https://clinicaltrials.gov/ct2/show/NCT04697264

Jul 6th, 2022 - BACKGROUND Endometrial cancer is the most common malignancy of the female genital tract. It is the fourth most common cancer in the UK with around 9,500 new cases in 2017, current lifetime risk being 1 in 36 women. The number of women diagnosed wi...

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
https://clinicaltrials.gov/ct2/show/NCT04634617

Jul 1st, 2022 - PRIMARY OBJECTIVE: I. To estimate and compare the prevalence of pelvic floor dysfunction in uterine cancer survivors by modality of treatment and to compare with a control group with no history of cancer using the Pelvic Floor Distress Inventory (...

Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
https://clinicaltrials.gov/ct2/show/NCT04586959

Jun 30th, 2022 - In most cases, patients who have early stage endometrial cancer undergo a surgery to remove the uterus, cervix, tubes, ovaries, and occasionally lymph nodes. This is usually done through a minimally invasive (not a large incision) surgery. To acco...

Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Primary Ovarian or Uterine Cancer
https://clinicaltrials.gov/ct2/show/NCT03325634

May 26th, 2022 - This is a phase I study with a primary objective to determine maximum tolerated dose (MTD) of 3 fraction stereotactic body radiation therapy (SBRT) for abdominopelvic recurrences of ovarian cancer (OC) and uterine papillary serous carcinoma (UPSC)...

see more →

News  214 results

Power-morcellation hysterectomies declined and most performed with no containment bag
https://www.mdedge.com/obgyn/article/256908/surgery/power-morcellation-hysterectomies-declined-and-most-performed-no
Diana Swift

Aug 9th, 2022 - The use of laparoscopic power morcellators for minimally invasive hysterectomy has significantly decreased, and while the use of containment bags increased after the U. S.

Power-Morcellation Hysterectomies Declined and Most Performed With No Containment Bag
https://www.medscape.com/viewarticle/978933

Aug 9th, 2022 - The use of laparoscopic power morcellators for minimally invasive hysterectomy has significantly decreased, and while the use of containment bags increased after the U.S. Food and Drug Administration's 2014 safety warning about power morcellators,...

Once Again, MD Anderson Rated Number One Cancer Hospital in US
https://www.medscape.com/viewarticle/978609

Aug 4th, 2022 - The University of Texas MD Anderson Cancer Center has once again been named the number one ranked cancer hospital in America in the annual ratings from US News & World Report. US News evaluated 914 hospitals and ranked the top 50 that treat cancer...

US News Issues Top Hospitals List, Now With Expanded Health Equity Measures
https://www.medscape.com/viewarticle/977912

Jul 26th, 2022 - For the seventh consecutive year, the Mayo Clinic in Rochester, Minnesota, took the top spot in the annual honor roll of best hospitals, published today by US News & World Report. This year's rankings, which marks the 33rd edition, showcase severa...

Cancer May Increase Risk of Type 2 Diabetes
https://www.medscape.com/viewarticle/976224

Jun 27th, 2022 - A large Danish study has found that cancer increases the risk of new-onset type 2 diabetes, especially certain types of cancer, most notably pancreatic malignancies. "Our study demonstrates that there is an elevated risk of developing diabetes if ...

see more →

Patient Education  5 results see all →